Dose Confirmation Efficacy Study (V260-007)

Study of the Efficacy, Safety, and Immunogenicity of V260 at Expiry

This study was designed to evaluate the safety of the investigational Rotavirus Vaccine and the efficacy to prevent Rotavirus Gastroenteritis.

The duration of treatment is 10 months.

Inclusion Criteria:

• Healthy infants

Exclusion Criteria:

• History of abdominal disorders from a birth defect, intussusception, or abdominal surgery
• Known or suspected problems with immune system
• Fever at time of immunization
• Prior administration of a rotavirus vaccine
• History of known prior rotavirus disease
• Chronic diarrhea, or failure to thrive